Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Cytokind announces recently published results in the peer-reviewed Multiple Sclerosis and Related Disorders journal, demonstrating that narrowband UVB (NB-UVB) phototherapy's broad anti-inflammatory ...
Psoriasis is a systemic disease affecting the body, not just the skin; awareness and management are crucial for patients.
Objective To investigate the association between peripheral disease activity and pre-eclampsia, gestational hypertension, preterm birth and fetal growth in women with psoriatic arthritis (PsA).Methods ...
Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across strict measures of peripheral ...
Childhood emotional trauma significantly elevates psoriasis risk by disrupting immune responses, new research reveals. Early ...
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 clinical study ...
Psoriatic arthritis disease activity levels appear to increase on average during perimenopause before decreasing slightly ...
Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback